ArticlePloS one2026
Transcription factor activity divergence across muscle atrophy conditions: A comparative analysis of spaceflight, aging, and disuse using decoupleR.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skeletal muscle atrophy arises from heterogeneous insults including spaceflight, aging, and immobilization. Prior studies have catalogued differentially expressed genes (DEGs) in each context, but the transcription factors (TFs) coordinating these programs remain inconsistently characterized across conditions, and gene-level overlap between conditions is small. Three mouse transcriptomic datasets were analyzed: NASA OSD-576 (Rodent Research-23) tibialis anterior muscle from spaceflight versus ground control animals; GSE145480 gastrocnemius muscle from 28-month-old versus 8-month-old mice as a sarcopenia model; and GSE273092 gastrocnemius muscle from mice subjected to ten days of hindlimb unloading versus weight-bearing controls as a disuse atrophy model. For each, gene-level Wald statistics from PyDESeq2 were used to infer TF activity with decoupleR's univariate linear model (ULM) against the CollecTRI mouse regulon (43,226 TF-target interactions, 1,165 TFs). TFs were classified as pan-atrophy, partial, or condition-specific based on |NES| ≥ 1.5 in 3, 2, or 1 conditions. Of 732 TFs scored, 47 (6.4%) were pan-atrophy, 161 (22.0%) partial, and 295 (40.3%) condition-specific. Pearson correlation of TF activity profiles was highest between spaceflight and disuse atrophy (r = 0.4573) and lowest between spaceflight and sarcopenia (r = 0.1459). Pan-atrophy regulators included the glucocorticoid receptor Nr3c1, Foxo1, the chromatin remodeller Smarca4, and the stress regulators Pml and Ing4; Stat1 crossed the threshold but showed a sign-discordant pattern, repressed in spaceflight and disuse but activated in sarcopenia. Spaceflight showed repression of Hsf1/Hsf2/Hsf4 and activation of Hdac7; sarcopenia uniquely activated Spi1, Stat5a, and Irf2; disuse atrophy uniquely activated Mlxipl and Ovol1. This comparative transcriptomic analysis reveals a small but biologically coherent set of pan-atrophy regulators dominated by glucocorticoid and FoxO signaling, alongside a much larger pool of condition-specific regulators encoding the stressor of origin, narrowing the candidate regulator list warranting further investigation for relevance to muscle wasting broadly and to spaceflight specifically.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.